Table 1 Clinical and pathologic characteristics of patients with mRNA SARS-CoV-2 vaccination during pregnancy.

19

41

Pfizer

1

2

39

Advanced maternal age

710

>90%

24

30

Pfizer

2

2

40

Post partum hemorrhage

630

>90%

29

37

Pfizer

1

4

34

None

1071

>90%

25

34

Moderna

2

4

37

Intrauterine growth restriction

385

<10%

27

41

Pfizer

1

4

37

None

668

10–25%

26

34

Moderna

2

4

38

Pregnancy induced hypertension

448

10–25%

28

30

Pfizer

2

4

39

None

507

25–50%

8

41

Pfizer

1

5

32

Placenta previa, advanced maternal age

378

50–75%

30

31

Pfizer

1

5

38

Cholestasis of pregnancy

590

75–90%

31

36

Pfizer

2

5

40

None

470

10–25%

32

37

Moderna

1

6

36

Premature rupture of membranes

366

<10%

18

31

Pfizer

1

6

39

Graves disease

565

50–75%

33

30

Pfizer

2

6

39

Intrauterine growth restriction in prior pregnancy

402

10–25%

10

33

Moderna

2

7

36

Intrauterine growth restriction

358

<10%

34

30

Pfizer

1

8

6

None

N/A

Fragmented

35

34

Pfizer

1

8

39

None

793

>90%

36

38

Pfizer

1

9

9

None

N/A

Fragmented

37

31

Pfizer

1

10

26

HELLP syndrome

134

<10%

38

37

Pfizer

1

10

36

Preeclampsia with severe features

400

10–25%

39

34

Pfizer

1

10

39

Small for gestational age

423

<10%

21

32

Pfizer

2

10

40

None

557

50–75%

40

34

Moderna

1

11

33

Premature rupture of membranes

449

<10%

4

40

Pfizer

1

13

16

None

N/A

N/A

6

33

Moderna

2

13

17

None

N/A

N/A

41

30

Pfizer

2

13

36

Fetal lower urinary tract obstruction

409

10–25%

42

34

Pfizer

1

13

39

In vitro fertilization

546

50–75%

43

32

Pfizer

1

13

40

Decreased fetal movement

520

25–50%

44

37

Pfizer

1

14

34

None

455

50–75%

17

35

Pfizer

1

14

39

Type II diabetes

529

50–75%

45

40

Pfizer

1

15

13

None

N/A

Fragmented

1

38

Moderna

1

16

8

None

N/A

N/A

15

35

Moderna

2

16

38

History of placenta accreta

361

<10%

46

29

Pfizer

1

18

23

Premature rupture of membranes

104

<10%

47

35

Pfizer

2

20

38

Pregnancy-induced hypertension

637

>90%

48

38

Pfizer

1

21

36

None

454

50–75%

5

34

Moderna

1

23

17

None

N/A

N/A

14

35

Moderna

2

25

37

Intrauterine growth restriction

291

<10%

11

24

Moderna

2

32

36

Preeclampsia with severe features

540

75–90%

13

32

Moderna

2

34

37

Gestational diabetes

424

10–25%

9

32

Pfizer

2

38

35

Preeclampsia with severe features

421

25–50%

22

33

Moderna

2

38

40

None

560

50–75%

16

39

Moderna

2

39

38

None

477

25–50%

12

31

Pfizer

2

45

36

Preeclampsia with severe features

424

25–50%

3

35

Moderna

2

46

9

None

N/A

N/A

7

38

Moderna

2

51

30

Pre-term labor

202

<10%

20

39

Moderna

2

65

39

None

586

75–90%

2

36

Pfizer

2

68

9

None

N/A

N/A

23

25

Pfizer

2

79

41

Non-reassuring fetal heart rate

514

25–50%